IntelGenx to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

IntelGenx to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

ID: 558338

(firmenpresse) - SAINT-LAURENT, QUEBEC -- (Marketwired) -- 08/30/17 -- IntelGenx Technologies Corp., (TSX VENTURE: IGX)(OTCQX: IGXT), today announced that its President and Chief Executive Officer, Dr. Horst Zerbe, is scheduled to present at the Rodman & Renshaw 19th Annual Global Investment Conference on Monday, September 11 at 12:30 p.m. Eastern Time at the at the Lotte New York Palace Hotel.

Dr. Zerbe will provide an overview of IntelGenx' business during the presentation and, along with Andre Godin, Executive Vice-President and Chief Financial Officer, will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

The presentation will be webcast live and archived for 90 days on the Company's website, , under "Investors".

About IntelGenx:

Established in 2003, IntelGenx is a leading oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform.

IntelGenx' highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. IntelGenx' state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full service capabilities to its clients. More information about the company can be found at .

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange), nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Source: IntelGenx Technologies Corp.



Contacts:
Stephen Kilmer
Investor Relations
(514) 331-7440 ext 232


Andre Godin, CPA, CA
Executive Vice-President and CFO




(514) 331-7440 ext 203

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Tauriga Sciences, Inc. Fully Retires $104,000 7.00% USD Convertible Debenture Issued to Union Capital LLC on May 28, 2015 IntelGenx Grants Stock Options
Bereitgestellt von Benutzer: Marketwired
Datum: 30.08.2017 - 20:30 Uhr
Sprache: Deutsch
News-ID 558338
Anzahl Zeichen: 0

contact information:
Town:

SAINT-LAURENT, QUEBEC



Kategorie:

Health & Nutrition



Diese Pressemitteilung wurde bisher 342 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"IntelGenx to Present at the 19th Annual Rodman & Renshaw Global Investment Conference"
steht unter der journalistisch-redaktionellen Verantwortung von

IntelGenx Technologies Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

IntelGenx Reports Third Quarter 2017 Financial Results ...

SAINT-LAURENT, QUEBEC -- (Marketwired) -- 11/09/17 -- IntelGenx Technologies Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Company" or "IntelGenx") today reported financial results for the third quarter ended September 30, 2017. A ...

Alle Meldungen von IntelGenx Technologies Corp.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z